Abstract
Up to now, over 200 patients with paracoccidioidomycosis (PCM) associated to HIV infection have already been reported; however, the central nervous system involvement in this coinfection was rarely reported. This paper presents a 35-year-old Brazilian male AIDS patient who developed pulmonary PCM successfully treated with itraconazole. At the antiretroviral therapy starting, he had 32 CD4+ T cells baseline count and high viral load levels. After 9 months, he presented severe fungal meningoencephalitis diagnosed by sublenticular enhanced nodular lesion at computerized tomography and magnetic resonance brain imaging and a positive Paracoccidiodes brasiliensis smear and culture from cerebrospinal fluid. At the time, a sixfold increase in CD4+ T cell count and undetectable viral load level were evidenced. The patient received amphotericin B during 1 year presenting slow but progressive clinical improvement, and he is currently asymptomatic and without neurological disabilities. To our knowledge, this is the second case report of a patient with neuroparacoccidioidomycosis associated to HIV infection.
References
Marini MM, Zanforlin T, Santos PC, et al. Identification and characterization of Tc1/mariner-like DNA transposons in genomes of the pathogenic fungi of the Paracoccidioides species complex. BMC Genom. 2010;11:130.
Wanke B, Londero AT. Epidemiology and paracoccidioidomycosis infection. In: Franco M, Lacaz CS, Restrepo-Moreno A, Del Negro G, editors. Paracoccidioidomycosis. Boca Raton, FL: CRC Press; 1994. p. 109–20.
Restrepo A, McEwen JG, Castaneda E. The habitat of Paracoccidiodes brasiliensis: how far from solving the riddle? Med Mycol. 2001;39:233–41.
Prado M, Silva MB, Laurenti R, et al. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz. 2009;104:513–21.
Franco M, Montenegro MR, Mendes RP, Marques SA, et al. Paracoccidioidomycosis: a recently proposed classification of its clinical forms. Rev Soc Bras Med Trop. 1987;20:129–32.
Mendes RP. The gamut of clinical manifestation. In: Franco M, da Lacaz CS, Restrepo-Moreno A, Del Negro G, editors. Paracoccidioidomicose. Boca Raton, FL: CRC Press; 1994. p. 233–58.
Franco M, Mendes RP, Moscardi-Bacchi M, et al. Paracoccidioidomycosis. Baillière’s Clin Trop Med Commun Dis. 1989;4:185–220.
Magalhães AC, Bacheschi LA, Caramelli P, et al. Paracoccidioidomycosis of the central nervous system: study of 5 cases by magnetic resonance. Rev Hosp Clin Fac Med São Paulo. 1993;48:94–7.
Lambertucci JR, Lana-Peixoto MA, Pitella JE. Paracoccidioidomycosis of the central nervous system. Rev Soc Bras Med Trop. 2001;34:395–6.
Pedroso VS, Vilela MDEC, Pedroso ER, et al. Paracoccidioidomycosis compromising the central nervous system: a systematic review of the literature. Rev Soc Bras Med Trop. 2009;42:691–7.
Maffei WE. Micoses do Sistema Nervoso Central. An Fac Med Univ São Paulo. 1943;29:297–327 [In Portuguese].
Francesconi F, do Valle ACF, Silva MT, Costa RL, Carregal E, Thalhari S. International issue: meningoencephalitis due to Paracoccidioides brasiliensis. Neurology. 2008;71:e65–7.
Nóbrega JPS, França AS. Neuroparacoccidioidomycosis. Franco M, Lacaz CS, Restrepo-Moreno A, Del-Negro G, editors. Paracoccidioidomycosis. Boca Raton, FL: CRC Press; 1994. p. 321–30.
Paniago AM, de Oliveira PA, Aguiar ES, et al. Neuroparacoccidioidomycosis: analysis of 13 cases observed in an endemic area in Brazil. Trans R Soc Trop Med Hyg. 2007;101:414–20.
Reis F, Collier OP, Souza TF, Lopes GP, Bronzatto E, Junior NAS, Pereira RM, Appenzeller S. Neuroparacoccidioidomycosis (NPCM): magnetic resonance imaging (MRI) findings. Mycopathologia. 2013;175:181–6.
Goldani LZ, Martinez R, Landell GA, et al. Paracoccidioidomycosis in a patient with acquired immunodeficiency syndrome. Mycopathologia. 1989;105:71–4.
Benard G, Duarte AJ. Paracoccidioidomycosis: a model for evaluation of the effects of human immunodeficiency virus infection on the natural history of endemic tropical diseases. Clin Infect Dis. 2000;31:1032–9.
Silva-Vergara ML, Teixeira AC, Curi VG, et al. Paracoccidioidomycosis associated with human immunodeficiency virus infection. Report of 10 cases. Med Mycol. 2003;41:259–63.
Morejón KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case control study. Am J Trop Med Hyg. 2009;80:359–66.
Bellissimo-Rodrigues F, Vitali LH, Martinez R. Serological diagnosis of paracoccidioidomycosis in HIV-coinfected patients. Mem Inst Oswaldo Cruz. 2010;105:904–7.
Finamor LP, Muccioli C, Martins MC, Rizzo LV, Belfort R Jr. Ocular and central nervous system paracoccidioidomycosis in a pregnant woman with acquired immunodeficiency syndrome. Am J Ophthalmol. 2002;134:456–9.
Shikanai-Yasuda MA, Telles Filho FQ, Mendes RP, et al. Guidelines in paracoccidioidomycosis. Rev Soc Bras Med Trop. 2006;39:297–310.
Lorenzoni PJ, Chang MR, Paniago AM, Salgado PR. Paracoccidioidomycosis meningitis: case report. Arq Neuropsiquiatr. 2002;60:1015–8.
Whittier S, Hopfer RL, Gilligan P. Elimination of false-positive serum reactivity in latex agglutination test for cryptococcal antigen in human immunodeficiency virus-infected population. J Clin Microbiol. 1994;32:2158–61.
Sorensen KN, Sobel RA, Clemons KV, et al. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis. Antimicrob Agents Chemother. 2000;44:1512–7.
Kamberi P, Sobel RA, Clemons KV, et al. Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis. Antimicrob Agents Chemother. 2007;51:998–1003.
Kethireddy S, Andes D. CNS pharmacokinetics of antifungal agents. Expert Opin Drug Metab Toxicol. 2007;3:573–81.
Koo HL, Hamill RJ, Andrade RA. Dug-drug interaction between itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis. Clin Infect Dis. 2007;45:e77–9.
de Almeida SM, Queiroz-Telles F, Teive HA, Ribeiro CE, Werneck LC. Central nervous system paracoccidioidomycosis: clinical features and laboratorial findings. J Infect. 2004;48:193–8.
Acknowledgments
Thanks to Mrs. Ângela Azôr for the technical assistance and to Fundação de Amparo a Pesquisa de Minas Gerais (FAPEMIG) for the financial support. Grant: APQ 01624-12.
Conflict of interest
The authors report no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Silva-Vergara, M.L., Rocha, I.H., Vasconcelos, R.R. et al. Central Nervous System Paracoccidioidomycosis in an AIDS Patient: Case Report. Mycopathologia 177, 137–141 (2014). https://doi.org/10.1007/s11046-014-9729-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-014-9729-5